advertisement
11.13.2 Betablocker and carbon anhydrase inhibitor (7)
Showing records 1 to 7
Display all abstracts in classification 11.13.2 Betablocker and carbon anhydrase inhibitor
Search within classification 11.13.2 Betablocker and carbon anhydrase inhibitor55601 Improvement in glaucoma patient quality of life by therapy switch to preservative-free timolol/dorzolamide fixed combination
Abegão Pinto L; Vandewalle E; Gerlier L; Stalmans I;
Ophthalmologica 2014; 231: 166-171
55664 Efficacy and safety of brinzolamide/timolol fixed combination compared with timolol in Japanese patients with open-angle glaucoma or ocular hypertension
Yoshikawa K; Kozaki J; Maeda H
Clinical Ophthalmology 2014; 8: 389-399
55287 The safety and efficacy of brinzolamide 1%/timolol 0.5% fixed combination versus dorzolamide 2%/timolol 0.5% in patients with open-angle glaucoma or ocular hypertension
Sezgin Akçay Bİ; Güney E; Bozkurt KT; Unlü C; Akçali G
Journal of Ocular Pharmacology and Therapeutics 2013; 29: 882-886
55764 A 4-year retrospective study of add-on therapy to the fixed combination of dorzolamide/timolol for the treatment of POAG
Hartleben-Matkin C; Prada D; Mancilla-Vences R
International Journal of Ophthalmology 2014; 7: 330-334
55603 Phase III safety and efficacy study of long-term brinzolamide/timolol fixed combination in Japanese patients with open-angle glaucoma or ocular hypertension
Nakajima M; Iwasaki N; Adachi M
Clinical Ophthalmology 2014; 8: 149-156
55661 Safety and efficacy of a fixed versus unfixed brinzolamide/timolol combination in Japanese patients with open-angle glaucoma or ocular hypertension
Nagayama M; Nakajima T; Ono J
Clinical Ophthalmology 2014; 8: 219-228
55749 Comparison of latanoprost/timolol with carbonic anhydrase inhibitor and dorzolamide/timolol with prostaglandin analog in the treatment of glaucoma
Inoue K; Soeda S; Tomita G
Journal of Ophthalmology 2014; 2014: 975429
